Impact of Lactobacillaceae supplementation on the multi-organ axis during MASLD

Abstract

The gut-liver axis plays a pivotal role in maintaining body homeostasis. Disruption of the gut-liver axis is linked to a multitude of diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD). Probiotic strains from the Lactobacillaceae family are commonly used to mitigate experimental MASLD. Over the years, numerous studies have demonstrated the efficacy of these probiotics, often focusing on the outcome of liver disease. This review aims to further understand MASLD as a systemic metabolic dysfunction and to highlight the effects of probiotics on multi-organ axis, including organs such as the gastrointestinal tract, pancreas, muscle, adipose tissue, and the immune system. We specifically discuss evidence on how supplementation with Lactobacillaceae strains may alleviate MASLD by not only restoring liver health but also by modulating the physiology of other organ systems.

Keywords

Lactobacillaceae; Microbiota; MASLD; Metabolic disease; Probiotics

Published in

Life Sciences
2024, Volume: 354, article number: 122948Publisher: PERGAMON-ELSEVIER SCIENCE LTD

SLU Authors

• Roos, Stefan

  • Department of Molecular Sciences, Swedish University of Agricultural Sciences
    

UKÄ Subject classification

Pharmacology and Toxicology
Microbiology in the medical area


Publication identifier

DOI: https://doi.org/10.1016/j.lfs.2024.122948

Permanent link to this page (URI)

https://res.slu.se/id/publ/131752